Consensus statement on optimizing management of EGFR mutation positive NSCLC patients
The International Association for the Study of Lung Cancer (IASLC) created the 2016 consensus statement on optimizing management of epidermal growth factor receptor (EGFR) mutation positive (M+) non-small cell lung cancer ...
May 23, 2016
0
11